Department of General Surgery, Faculty of Medicine, Hadassah Medical Organization, Hebrew University of Jerusalem, POB 12000, 91120, Jerusalem, Israel.
Department of Gynecology, Faculty of Medicine, Hadassah Medical Organization, Hebrew University of Jerusalem, Jerusalem, Israel.
Tech Coloproctol. 2022 Dec;26(12):981-989. doi: 10.1007/s10151-022-02699-6. Epub 2022 Sep 12.
Low anterior resection syndrome (LARS) is a functional disorder that may follow restorative proctectomy. The aim of this study was to evaluate the long-term incidence and risk factors for LARS following surgery for rectal cancer.
A retrospective study was performed on patients from a prospectively maintained database, who underwent a restorative proctectomy between January 2014 and December 2019 at Hadassah Hebrew University Medical Center. The study cohort was divided into two groups: patients following partial proctectomy with a partial mesorectal excision and a colorectal anastomosis (PME group) and patients following total proctectomy with total mesorectal excision and a coloanal anastomosis (TME group). The incidence and severity of LARS were evaluated using the LARS questionnaire. Risk factors for LARS were also evaluated.
A total of 240 patients (male: female ratio 134:106, median age 64 years [interquartile range 55-71 years]) were included in the analysis. There were 160 patients in the PME group and 80 patients in the TME group. The overall incidence of LARS was 37.4% (26.5% major LARS and 10.9% minor LARS). Major LARS was observed in 53.8% of patients who underwent TME and in 12.7% of patients who underwent PME (p < 0.001). On multivariate analysis, distance of the anastomosis from the anal verge, TME, and neoadjuvant radiotherapy were independent prognostic factors for LARS. The incidence and severity of LARS were significantly lower in patients with longer follow-up (p = 0.05).
Significant improvement in LARS can be expected with longer follow-up. Distance of the anastomosis from the anal verge, TME and neoadjuvant radiotherapy are independent risk factors for LARS.
低位前切除综合征(LARS)是一种可能在直肠重建术后发生的功能性障碍。本研究旨在评估直肠癌手术后 LARS 的长期发生率及相关风险因素。
本研究为回顾性队列研究,分析了 2014 年 1 月至 2019 年 12 月期间在哈达萨希伯来大学医学中心接受直肠重建术的患者的前瞻性数据库资料。研究队列分为两组:接受部分直肠切除术伴部分直肠系膜切除术和结直肠吻合术(PME 组)的患者,以及接受全直肠切除术伴全直肠系膜切除术和结肠直肠吻合术(TME 组)的患者。采用 LARS 问卷评估 LARS 的发生率和严重程度。同时还评估了 LARS 的风险因素。
共纳入 240 例患者(男:女 134:106,中位年龄 64 岁[55-71 岁])。其中 160 例患者为 PME 组,80 例患者为 TME 组。LARS 的总体发生率为 37.4%(主要 LARS 占 53.8%,次要 LARS 占 10.9%)。TME 组中 53.8%的患者出现主要 LARS,而 PME 组中仅 12.7%的患者出现主要 LARS(p<0.001)。多变量分析显示,吻合口距肛缘的距离、TME 和新辅助放疗是 LARS 的独立预后因素。随访时间较长的患者 LARS 的发生率和严重程度显著降低(p=0.05)。
随着随访时间的延长,LARS 可能会显著改善。吻合口距肛缘的距离、TME 和新辅助放疗是 LARS 的独立危险因素。